companydata.dkcompanydata.dk

Signum Life Science ApS: Financial statements 2020

CVR: 36559241

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

Signum Life Science ApS (CVR 36559241) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 8,099,776 and a net result of DKK 1,046,195 compared with DKK 3,795,326 the year before. That is a decrease of 22.5% compared with the year before. Equity in the 2020 report amounted to DKK 128,191,993. The solvency ratio was 81.1%. The company had 32 employees in the financial year.

Gross Profit
DKK 8,099,776
Profit/Loss
DKK 1,046,195
Equity
DKK 128,191,993
Total Assets
DKK 157,991,729
Employees
32

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-8.1M1M128.2M32
2019-10.5M3.8M129.2M28
2018-12M4.1M127.5M21
2017-12.5M5.5M125.8M-
2016-11.4M4.8M122.5M16

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Signum Life Science ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Thomas Bo Bjørn Klee joins the board of Signum Life Science ApSMay 15, 2020

As of May 15, 2020, Thomas Bo Bjørn Klee has joined the board of directors of Signum Life Science ApS.

Lars Møller joins the board of Signum Life Science ApSMay 15, 2020

As of May 15, 2020, Lars Møller has joined the board of directors of Signum Life Science ApS.

Andreas Daugaard Jørgensen joins the board of Signum Life Science ApSMay 15, 2020

As of May 15, 2020, Andreas Daugaard Jørgensen has joined the board of directors of Signum Life Science ApS.

Thomas Bo Bjørn Klee leaves the board of Signum Life Science ApSMay 14, 2020

As of May 14, 2020, Thomas Bo Bjørn Klee has left the board of directors of Signum Life Science ApS.

Lars Møller leaves the board of Signum Life Science ApSMay 14, 2020

As of May 14, 2020, Lars Møller has left the board of directors of Signum Life Science ApS.

Andreas Daugaard Jørgensen leaves the board of Signum Life Science ApSMay 14, 2020

As of May 14, 2020, Andreas Daugaard Jørgensen has left the board of directors of Signum Life Science ApS.

Signum Life Science ApS: The 2019 annual report is outApr 27, 2020

Signum Life Science ApS has published its annual report for 2019. Gross profit came to DKK 10,457,442, and the net result was DKK 3,795,326.

Allan Karne Levisen joins the board of Signum Life Science ApSMar 30, 2020

As of March 30, 2020, Allan Karne Levisen has joined the board of directors of Signum Life Science ApS.

Cecilie Betzer leaves the board of Signum Life Science ApSMar 30, 2020

As of March 30, 2020, Cecilie Betzer has left the board of directors of Signum Life Science ApS.

Allan Karne Levisen leaves the board of Signum Life Science ApSMar 29, 2020

As of March 29, 2020, Allan Karne Levisen has left the board of directors of Signum Life Science ApS.

About Signum Life Science ApS

Signum Life Science ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named DLI Market Intelligence ApS. The management consists of Thomas Senderovitz. The board consists of Anja Cecilie Verhaug (chair), Mari-Ann Retz, Anne Marie Hedegaard Byskov and Søren Hvidsten Nielsen. The company is owned by DLI - DANSK LÆGEMIDDEL INFORMATION A/S and TJELLESEN MAX JENNE A/S. The company has 53 employees (2026). In 2025, the company reported a gross profit of DKK -67,441,461 and a net result of DKK -66,049,966 compared with DKK -5,936,982 the year before. Equity in the 2025 report amounted to DKK 40,680,589.

Source: annual report 2025, Danish Business Authority